EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan

Hiroko Setoyama iD, Takehisa Watanabe iD, Shiho Miyase, Masakuni Tateyama, Motohiko Tanaka, Nobuhiro Minami, Masato Sasaki, Shunpei Hashigo, Kotaro Fukubayashi, Shotaro Ishii, Mutsuo Koga, Ryo Ichikawa und 12 weitere

Journal of Clinical Laboratory Analysis · 2026

DOI: 10.1002/jcla.70286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Hiroko Setoyama und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Hepatitis C, Triage, Hepacivirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Japan, the hepatitis C virus (HCV) care cascade is constrained at the transition from anti‐HCV antibody screening to confirmatory HCV ribonucleic acid (HCV RNA) testing in nonspecialist departments. As HCV prevalence declines and the population ages, the two‐step antibody‐to‐RNA algorithm becomes less efficient and vulnerable to loss to follow‐up. We evaluated whether the Elecsys HCV Duo assay could function as a triage test to strengthen linkage to care.

Methods

We conducted a two‐part study in Kumamoto Prefecture, Japan. First, a survey of 19 specialized institutions assessed hepatitis virus testing practices and downstream evaluation in nonspecialist departments. Second, 479 serum samples from patients undergoing HCV RNA quantification at four hospitals were prospectively evaluated using the Elecsys HCV Duo assay, with detection rates stratified by viral load.

Results

Nonspecialist departments accounted for 86.6% of in‐hospital anti‐HCV testing; however, among 1416 anti‐HCV–positive individuals identified outside gastroenterology departments, only 22.7% underwent confirmatory HCV RNA testing. In the prospective evaluation of 479 samples, HCVcAg sensitivity and specificity versus HCV RNA were 62.8% and 99.8%, respectively. Detection rates increased with viral load, from 0% at ≤ 4.0 log 10 IU/mL to 16.7% at 4.1–5.5 log 10 IU/mL and 86.2% at ≥ 5.6 log 10 IU/mL.

Conclusion

A vulnerability in the HCV care cascade lies at the transition from screening to confirmatory evaluation in nonspecialist settings. When implemented as a triage test within referral pathways, the Elecsys HCV Duo assay may improve linkage to specialist care while reserving HCV RNA testing for downstream confirmation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CTriageHepacivirusHumansJapanHepatitis C AntibodiesRNA, ViralFemaleMaleProspective StudiesSensitivity and SpecificityMiddle AgedImmunoassay

Stichwörter der Autor:innen

Elecsys HCV DuoHCV care cascadeHCV core antigenhepatitis C viruslinkage to carenonspecialist settingsscreening strategy

Substanzen

Hepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Gastroenterology and Hepatology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
  • National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Saiseikai Kumamoto Hospital, Kumamoto, Japan.
  • Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Kumamoto Rosai Hospital, Kumamoto, Japan.

ORCID-Profile: Hiroko Setoyama, Takehisa Watanabe, Kentaro Matsuura, Yasuhito Tanaka

Förderung

  • Japan Agency for Medical Research and Development
  • Roche Diagnostics

Zitieren

APA

Setoyama, H., Watanabe, T., Miyase, S., Tateyama, M., Tanaka, M., Minami, N., Sasaki, M., Hashigo, S., Fukubayashi, K., Ishii, S., Koga, M., Ichikawa, R., Iwashita, H., Sakai, Y., Motohara, T., Tomita, K., Nakata, A., Kai, Y., Kounoe, T., …, & Tanaka, Y. (2026). Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70286

Vancouver

Setoyama H, Watanabe T, Miyase S, Tateyama M, Tanaka M, Minami N, et al. Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70286

BibTeX
@article{Setoyama2026,
  author = {Setoyama, Hiroko and Watanabe, Takehisa and Miyase, Shiho and Tateyama, Masakuni and Tanaka, Motohiko and Minami, Nobuhiro and Sasaki, Masato and Hashigo, Shunpei and Fukubayashi, Kotaro and Ishii, Shotaro and Koga, Mutsuo and Ichikawa, Ryo and Iwashita, Hirofumi and Sakai, Yoshinari and Motohara, Toshihiko and Tomita, Kohei and Nakata, Akinori and Kai, Yutaka and Kounoe, Takeyasu and Haraoka, Katsuki and Inoue, Takako and Suzuki, Takanori and Matsuura, Kentaro and Tanaka, Yasuhito},
  title = {Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  doi = {10.1002/jcla.70286}
}
Kostenlos starten →